News
Pharmaceutical Technology on MSN4d
Scancell shares up 6% after NHS partnership for fast-track cancer vaccine trialScancell stated that data from one of the cohorts in the trial, who received a first iteration of the vaccine alongside two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback